Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPhoenix Group Holdings Regulatory News (PHNX)

  • There is currently no data for PHNX

Board Changes

18 Aug 2025 10:00

RNS Number : 6033V
Phoenix Group Holdings PLC
18 August 2025
 

LEI: 2138001P49OLAEU33T68

 

18 August 2025

 

Phoenix Group Holdings plc - Board Changes

 

The Board of Phoenix Group Holdings plc ("Phoenix" or the "Group") announces the following changes:

 

· Belinda Richards, Group Independent Non-Executive Director, will be retiring from the Board on 24 August 2025, having served almost eight years.

 

· Karin Cook will be appointed to the Group Board as an Independent Non-Executive Director, and as a member of its Risk and Sustainability Committees with effect from 25 August 2025. Within the Group, Karin is currently an Independent Non-Executive Director of the Group's Life Companies[1] Boards and a member of its Risk Committee, and SunLife Limited. Karin is also an Independent Non-Executive Director of NatWest Holdings Limited (holding company of NatWest Group's ring-fenced operations including its retail, commercial and wealth businesses) and a member of its Board Audit and Remuneration Committees. Karin brings over thirty years of customer-focused, digital, operational and transformation experience gained from previous leadership roles in multiple large groups (including as the Chief Operating Officer of Quilter plc, Director, Group Operations at Lloyds Banking Group and senior roles at HSBC, Morgan Stanley and Goldman Sachs). Karin has a commitment to diversity, equity and inclusion and has been recognised in the past in the LGBT Great's Top 50 Executive Allies, the FT OUTstanding LGBT+ Role Model list and as Stonewall Senior Champion of the Year.

 

· Mark Gregory, Group Independent Non-Executive Director and Chair of the Group Board Risk Committee will be appointed as an Independent Non-Executive Director of the Group's Life Companies Boards, member of the Life Companies Nomination Committee and also Chair of its Risk Committee with effect from 25 August 2025.

 

· Eleanor Bucks, Group Independent Non-Executive Director will be appointed as a member of the Group Audit Committee with effect from 25 August 2025.

 

· David Scott, Group Shareholder Nominated Non-Executive Director by Aberdeen Group plc ("Aberdeen") will retire from the Board on 31 August 2025.

 

· Siobhan Boylan, Chief Financial Officer ("CFO") of Aberdeen will be appointed in his place with effect from 1 September 2025. Siobhan has strong executive director level experience in her current role at Aberdeen and previous roles as CFO of Coutts & Co and CFO of Brewin Dolphin (a constituent of the FTSE 250 until its acquisition by Royal Bank of Canada in 2022). Until recently, she was also a Non-Executive Director of Jupiter Fund Management plc bringing additional experience in a non-executive capacity to the Board.

 

Commenting on the changes, Sir Nicholas Lyons, Chair of Phoenix said:

"On behalf of the Board, I would like to thank Belinda for her commitment, challenge and outstanding contribution to the Group during her tenure and I wish her every success for the future.

 

We are delighted that Karin and Mark have agreed to take on additional responsibilities. Their appointments are aligned to further increasing interaction and connectivity, whilst maintaining independence between our Group and Life Companies' Boards with their collective backgrounds being of great value to discussions at both board levels.

 

Both Eleanor and Karin will provide additional skills and ensure the required membership composition for their respective committees is maintained in accordance with the UK Corporate Governance Code 2024. Their strong challenge and experience will be welcomed by the current members of the Audit, Risk and Sustainability committees.

 

Finally, I would like to thank David for his excellent contribution to the Board since joining on 11 May 2023. We wish David every success and happiness in his retirement, and I look forward to welcoming Siobhan as a new Non-Executive Director to the Board."

 

This announcement is made pursuant to LR 6.4.6 and 6.4.8 of the Listing Rules. There is no further information required to be notified under Listing Rule 6.4.8 with reference to Karin Cook and Siobhan Boylan's appointments referenced above.

 

Enquiries:

Media

Shellie Wells, Corporate Communications Director, Phoenix Group

+44 (0) 204 559 3031

Investors

Claire Hawkins, Director of Corporate Affairs & Brand, Phoenix Group+44 (0) 204 559 3161

Tom Blackwell, Managing Director, FTI

+44 (0) 7747 133 919

Joanne Roberts, Investor Relations Director, Phoenix Group

+44 (0) 204 559 4673

 


[1] The term "Life Companies" refers collectively to the Group's insurance subsidiaries: Phoenix Life CA Limited, Phoenix Life Limited, ReAssure Life Limited, ReAssure Limited and Standard Life Assurance Limited.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAPKPBDABKDBFD
Date   Source Headline
24th Feb 20262:25 pmRNSChange of Company Name
18th Feb 20262:12 pmRNSAppointment of Corporate Broker
6th Feb 20261:52 pmRNSDirector/PDMR Shareholding
2nd Feb 202611:02 amRNSTotal Voting Rights
6th Jan 20261:31 pmRNSDirector/PDMR Shareholding
2nd Jan 202611:06 amRNSTotal Voting Rights
18th Dec 20252:38 pmRNSCompletion of Redemption at Maturity
18th Dec 20252:38 pmRNSCompletion of Redemption at Maturity
12th Dec 20252:49 pmRNSBlock listing Return
8th Dec 202511:08 amRNSDirector/PDMR Shareholding
1st Dec 20251:57 pmRNSTotal Voting Rights
24th Nov 20255:20 pmRNSBlock Listing Application
24th Nov 20257:09 amRNSLIST 2025 Results Show Robust Capital Position
6th Nov 20253:47 pmRNSDirector/PDMR Shareholding
3rd Nov 202512:01 pmRNSTotal Voting Rights
31st Oct 20253:10 pmRNSDirector/PDMR Shareholding
7th Oct 20251:20 pmRNSDirector/PDMR Shareholding
1st Oct 202512:38 pmRNSTotal Voting Rights
17th Sep 20252:40 pmRNSPublication of a Supplementary Prospectus
10th Sep 20252:51 pmRNSDirector/PDMR Shareholding
8th Sep 20255:23 pmRNSDirector/PDMR Shareholding
8th Sep 20257:00 amRNS2025 Interim Results
1st Sep 202510:00 amRNSTotal Voting Rights
18th Aug 202510:00 amRNSBoard Changes
6th Aug 202512:53 pmRNSDirector/PDMR Shareholding
1st Aug 202510:18 amRNSTotal Voting Rights
8th Jul 20253:31 pmRNSDirector/PDMR Shareholding
1st Jul 202512:26 pmRNSTotal Voting Rights
26th Jun 20259:00 amRNSBoard Changes
13th Jun 20253:00 pmRNSPublication of Prospectus
12th Jun 20252:43 pmRNSBlock listing Return
9th Jun 202512:25 pmRNSDirector/PDMR Shareholding
2nd Jun 202512:44 pmRNSTotal Voting Rights
23rd May 20253:02 pmRNSDirector/PDMR Shareholding
20th May 202510:00 amRNSDirector Declaration
13th May 20253:34 pmRNSResult of AGM
7th May 20254:20 pmRNSDirector/PDMR Shareholding
1st May 202510:33 amRNSTotal Voting Rights
10th Apr 20252:37 pmRNSDirector/PDMR Shareholding
8th Apr 20253:10 pmRNSDirector/PDMR Shareholding
3rd Apr 20251:35 pmRNSNotice of AGM
1st Apr 20252:52 pmRNSDirector/PDMR Shareholding
1st Apr 20252:42 pmRNSTotal Voting Rights
26th Mar 20253:46 pmRNSDirector/PDMR Shareholding
24th Mar 20255:43 pmRNSDirector/PDMR Shareholding
21st Mar 202511:56 amRNSDirector/PDMR Shareholding
20th Mar 20254:19 pmRNSDirector/PDMR Shareholding
19th Mar 20254:26 pmRNSDirector/PDMR Shareholding
19th Mar 20252:15 pmRNSDirector/PDMR Shareholding
17th Mar 20257:00 amRNS2024 Annual Financial Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.